BPH Global Ltd (ASX:BP8)
Australia · Delayed Price · Currency is AUD 0.0020
0.00 (0.00%)
At close: Jul 23, 2025, 4:00 PM AEST
BPH Global Company Description
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds.
Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries.
The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023.
BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
BPH Global Ltd
| Country | Australia |
| Founded | 1984 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Matthew Leonard |
Contact Details
Address: Block Arcade, 96 Elizabeth St. Melbourne, 3000 Australia | |
| Phone | 61 2 9088 2049 |
| Website | scu.com.sg |
Stock Details
| Ticker Symbol | BP8 |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000SCU9 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Matthew Robert Leonard | MD and Executive Director |
| Francesco Cannavo | Part-Time Executive Director |
| Chow-Yee Koh | Chief Financial Officer |
| Justyn Peter Stedwell B.Com, B.Com. | Company Secretary |